Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...
From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...
The U.S. Treasury Department said on Thursday that New York-based insurer MetLife's unit, American Life Insurance Company, ...
Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...
We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
Travel + Leisure on MSN22h
I’ve Traveled to 39 Countries With Type 1 Diabetes — Here's What It's LikeKrista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...
The company has two approved medical devices in China, namely reusable insulin injection pen (GanleePen), and disposable pen ... Gan & Lee will also actively develop new chemical entities and ...
The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how much insulin is administered, with the data uploaded to an app ...
The company has historically increased its addressable market by entering into new territories. It still has plenty of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback